NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76420-558-30 | 76420-558 | HUMAN PRESCRIPTION DRUG | SPIRONOLACTONE | SPIRONOLACTONE | TABLET, FILM COATED | ORAL | 20230407 | N/A | ANDA | ANDA089424 | Asclemed USA, Inc. | SPIRONOLACTONE | 100 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-558-30) |
76420-558-60 | 76420-558 | HUMAN PRESCRIPTION DRUG | SPIRONOLACTONE | SPIRONOLACTONE | TABLET, FILM COATED | ORAL | 20230407 | N/A | ANDA | ANDA089424 | Asclemed USA, Inc. | SPIRONOLACTONE | 100 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-558-60) |
76420-558-90 | 76420-558 | HUMAN PRESCRIPTION DRUG | SPIRONOLACTONE | SPIRONOLACTONE | TABLET, FILM COATED | ORAL | 20230407 | N/A | ANDA | ANDA089424 | Asclemed USA, Inc. | SPIRONOLACTONE | 100 mg/1 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-558-90) |